---
title: General Pathology
order: 1
category: Pathology
status: complete
last_updated: '2025-01-09'
---

# General Pathology

## Overview

General pathology is the study of basic disease mechanisms that affect cells, tissues, and organs. It encompasses the fundamental processes underlying disease, including cellular injury, inflammation, repair, neoplasia, and hemodynamic disorders. Understanding these mechanisms is essential for comprehending specific diseases and their clinical manifestations.

### Core Concepts
- **Disease**: Deviation from normal structure or function
- **Etiology**: Cause of disease (genetic, infectious, toxic, etc.)
- **Pathogenesis**: Mechanism of disease development
- **Morphology**: Structural changes in cells and tissues
- **Clinical correlation**: Relationship between pathology and symptoms

## Cellular Responses to Injury

### Cellular Adaptations

#### Hyperplasia
- **Definition**: Increase in cell number
- **Mechanisms**: Enhanced proliferation, stem cell activation
- **Examples**: Endometrial hyperplasia, prostate hyperplasia
- **Regulation**: Growth factors, hormones

#### Hypertrophy
- **Definition**: Increase in cell size
- **Mechanisms**: Increased protein synthesis, organelle production
- **Examples**: Cardiac hypertrophy, muscle hypertrophy
- **Triggers**: Increased workload, growth factors

#### Atrophy
- **Definition**: Decrease in cell size and number
- **Mechanisms**: Reduced protein synthesis, increased degradation
- **Types**: Physiologic (aging) vs pathologic (disuse)
- **Examples**: Muscle atrophy, brain atrophy

#### Metaplasia
- **Definition**: Replacement of one cell type with another
- **Mechanism**: Reprogramming of stem cells
- **Examples**: Barrett esophagus, bronchial squamous metaplasia
- **Significance**: Often precedes dysplasia

#### Dysplasia
- **Definition**: Abnormal cellular development
- **Features**: Loss of uniformity, increased mitoses
- **Examples**: Cervical dysplasia, bronchial dysplasia
- **Reversibility**: May be reversible if stimulus removed

### Cell Death Mechanisms

#### Apoptosis (Programmed Cell Death)
- **Characteristics**: Cell shrinkage, chromatin condensation, membrane blebbing
- **Pathways**: Intrinsic (mitochondrial) and extrinsic (death receptor)
- **Regulation**: p53, Bcl-2 family, caspases
- **Functions**: Development, tissue homeostasis, immune selection

#### Necrosis
- **Characteristics**: Cell swelling, membrane breakdown, inflammation
- **Types**: Coagulative, liquefactive, caseous, fat, fibrinoid
- **Causes**: Ischemia, toxins, infections, trauma
- **Consequences**: Inflammatory response, tissue damage

#### Other Forms of Cell Death
- **Autophagy**: Self-digestion for cellular recycling
- **Pyroptosis**: Inflammatory programmed cell death
- **Necroptosis**: Programmed necrosis
- **Ferroptosis**: Iron-dependent lipid peroxidation

## Acute Inflammation

### Vascular Changes
- **Vasodilation**: Increased blood flow, mediated by nitric oxide, prostaglandins
- **Increased permeability**: Plasma protein extravasation
- **Blood flow changes**: Initial vasoconstriction, then sustained vasodilation

### Cellular Events
1. **Margination**: Leukocytes move to vessel periphery
2. **Rolling**: Selectin-mediated loose adhesion
3. **Adhesion**: Integrin-mediated firm attachment
4. **Transmigration**: Movement through vessel wall
5. **Chemotaxis**: Directed migration to injury site

### Inflammatory Mediators

#### Vasoactive Mediators
- **Histamine**: Immediate vasodilation and permeability
- **Serotonin**: Platelet-derived vasoactive amine
- **Nitric oxide**: Vasodilation, antiplatelet effects
- **Prostaglandins**: Pain, fever, vasodilation

#### Chemotactic Factors
- **C5a**: Complement-derived chemokine
- **LTB4**: Leukotriene B4, neutrophil chemotaxis
- **Bacterial products**: fMLP, endotoxin
- **Cytokines**: IL-8, MCP-1

#### Plasma Protein Systems
- **Complement**: C3a, C5a (anaphylatoxins), MAC
- **Kinin system**: Bradykinin (pain, vasodilation)
- **Coagulation**: Thrombin, fibrin
- **Fibrinolytic**: Plasmin

### Outcomes of Acute Inflammation
1. **Resolution**: Complete restoration to normal
2. **Healing by connective tissue**: Scar formation
3. **Abscess formation**: Suppurative inflammation
4. **Chronic inflammation**: Persistent inflammation

## Chronic Inflammation

### Characteristics
- **Duration**: Weeks to years
- **Cells**: Macrophages, lymphocytes, plasma cells
- **Tissue changes**: Fibrosis, angiogenesis
- **Causes**: Persistent infections, autoimmune diseases, foreign materials

### Macrophage Activation
- **M1 (Classical)**: Pro-inflammatory, antimicrobial
- **M2 (Alternative)**: Anti-inflammatory, tissue repair
- **Functions**: Phagocytosis, antigen presentation, cytokine production

### Granulomatous Inflammation
- **Definition**: Chronic inflammation with epithelioid cells
- **Formation**: Macrophage fusion, giant cell formation
- **Examples**: Tuberculosis, sarcoidosis, foreign body reactions
- **Types**: Caseating vs non-caseating

## Tissue Repair and Wound Healing

### Regeneration
- **Definition**: Replacement with identical tissue
- **Requirements**: Intact tissue architecture, proliferative capacity
- **Cell types**: Labile (continuous), stable (facultative), permanent (non-dividing)
- **Examples**: Liver regeneration, intestinal epithelium

### Repair by Scar Formation

#### Phases of Wound Healing
1. **Hemostasis**: Platelet aggregation, coagulation cascade
2. **Inflammation**: Neutrophil and macrophage infiltration
3. **Proliferation**: Fibroblast proliferation, angiogenesis, epithelialization
4. **Maturation**: Collagen remodeling, scar maturation

#### Growth Factors
- **PDGF**: Platelet-derived growth factor
- **TGF-Î²**: Transforming growth factor beta
- **FGF**: Fibroblast growth factor
- **VEGF**: Vascular endothelial growth factor

#### Collagen Synthesis and Maturation
- **Type III collagen**: Early, weak fibers
- **Type I collagen**: Mature, strong fibers
- **Cross-linking**: Increases tensile strength
- **Remodeling**: Continuous process for months

### Factors Affecting Healing
- **Local**: Blood supply, infection, mechanical stress
- **Systemic**: Age, nutrition, diabetes, steroids
- **Wound type**: Clean vs contaminated, size, location

## Hemodynamic Disorders

### Edema
- **Definition**: Excess fluid in interstitial spaces
- **Mechanisms**: Increased hydrostatic pressure, decreased oncotic pressure, lymphatic obstruction, increased vascular permeability
- **Types**: Transudate vs exudate
- **Clinical examples**: Heart failure, nephrotic syndrome, inflammation

### Hyperemia and Congestion
- **Hyperemia**: Increased blood flow (active)
- **Congestion**: Reduced venous outflow (passive)
- **Acute**: Reversible changes
- **Chronic**: Tissue fibrosis, organ dysfunction

### Hemorrhage
- **Types**: Petechiae, purpura, ecchymoses, hematoma
- **Causes**: Trauma, coagulation disorders, vascular abnormalities
- **Consequences**: Anemia, shock, organ compression

### Thrombosis
- **Virchow's triad**: Endothelial injury, blood flow abnormalities, hypercoagulability
- **Arterial thrombi**: Platelet-rich, white thrombi
- **Venous thrombi**: Fibrin-rich, red thrombi
- **Consequences**: Occlusion, embolization

### Embolism
- **Definition**: Intravascular material carried by blood
- **Types**: Thromboembolism, fat embolism, air embolism, amniotic fluid embolism
- **Pulmonary embolism**: Most common, potentially fatal
- **Systemic embolism**: Stroke, organ infarction

### Infarction
- **Definition**: Tissue necrosis due to ischemia
- **Types**: White (anemic) vs red (hemorrhagic)
- **Factors**: Vascular anatomy, collateral circulation, oxygen demand
- **Examples**: Myocardial infarction, cerebral infarction

## Shock

### Definition and Pathophysiology
- **Definition**: Systemic hypoperfusion due to reduced cardiac output or reduced effective circulating volume
- **Cellular effects**: ATP depletion, membrane dysfunction, cell death
- **Compensatory mechanisms**: Sympathetic activation, RAAS, ADH

### Types of Shock
1. **Cardiogenic**: Heart failure (MI, arrhythmias)
2. **Hypovolemic**: Blood/fluid loss (hemorrhage, dehydration)
3. **Distributive**: Vasodilation (septic, anaphylactic, neurogenic)
4. **Obstructive**: Impaired venous return (PE, tamponade)

### Stages of Shock
- **Compensated**: Maintained blood pressure
- **Decompensated**: Hypotension, organ dysfunction
- **Irreversible**: Multiple organ failure, death

## Environmental and Nutritional Diseases

### Environmental Injuries
- **Thermal injury**: Burns, hypothermia
- **Electrical injury**: Cardiac arrhythmias, tissue damage
- **Radiation injury**: DNA damage, cancer risk
- **Chemical injury**: Toxic exposures, poisoning

### Nutritional Disorders
- **Protein-energy malnutrition**: Kwashiorkor, marasmus
- **Vitamin deficiencies**: Scurvy, rickets, beriberi
- **Mineral deficiencies**: Iron, zinc, calcium
- **Obesity**: Metabolic syndrome, cardiovascular disease

## Genetic Disorders

### Single Gene Disorders
- **Autosomal dominant**: Huntington disease, familial hypercholesterolemia
- **Autosomal recessive**: Cystic fibrosis, sickle cell disease
- **X-linked**: Hemophilia, Duchenne muscular dystrophy
- **Mitochondrial**: MELAS, Leber hereditary optic neuropathy

### Chromosomal Disorders
- **Numerical**: Trisomy 21 (Down syndrome), monosomy X (Turner syndrome)
- **Structural**: Deletions, duplications, translocations
- **Mosaicism**: Different cell lines in same individual

### Complex Genetic Disorders
- **Multifactorial**: Gene-environment interactions
- **Examples**: Diabetes, hypertension, cancer
- **Polygenic**: Multiple genes contribute

## Neoplasia Fundamentals

### Benign vs Malignant Tumors

#### Benign Characteristics
- **Growth**: Slow, expansive
- **Borders**: Well-demarcated
- **Metastasis**: None
- **Differentiation**: Well-differentiated

#### Malignant Characteristics
- **Growth**: Rapid, invasive
- **Borders**: Poorly defined
- **Metastasis**: Present
- **Differentiation**: Variable, often poor

### Tumor Classification
- **Epithelial tumors**: Carcinomas
- **Mesenchymal tumors**: Sarcomas
- **Hematopoietic tumors**: Leukemias, lymphomas
- **Neural tumors**: Gliomas, neuroblastomas

### Carcinogenesis
- **Initiation**: DNA damage, oncogene activation
- **Promotion**: Clonal expansion
- **Progression**: Additional mutations, metastasis
- **Hallmarks**: Sustained proliferation, evading growth suppressors, resisting cell death

## Clinical Applications

### Diagnostic Pathology
- **Histopathology**: Tissue examination
- **Cytopathology**: Cell examination
- **Immunohistochemistry**: Protein detection
- **Molecular pathology**: Genetic analysis

### Biomarkers
- **Diagnostic**: Identify disease
- **Prognostic**: Predict outcome
- **Predictive**: Response to therapy
- **Monitoring**: Disease progression

### Therapeutic Implications
- **Targeted therapy**: Specific molecular targets
- **Personalized medicine**: Individual patient characteristics
- **Drug development**: Understanding disease mechanisms
- **Prevention**: Risk factor modification

## Key Points

- General pathology provides the foundation for understanding all diseases
- Cellular adaptations represent responses to environmental changes
- Cell death occurs through multiple mechanisms with different consequences
- Inflammation is a protective response that can become pathologic
- Tissue repair involves regeneration and scar formation
- Hemodynamic disorders affect tissue perfusion and function
- Environmental and genetic factors contribute to disease development
- Neoplasia represents uncontrolled cellular growth and differentiation
- Understanding pathologic mechanisms guides diagnosis and treatment
- Integration of morphology with molecular findings enhances patient care

## References

1. Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Elsevier; 2020.
2. Rubin R, Strayer DS, Rubin E. Rubin's Pathology: Clinicopathologic Foundations of Medicine. 7th ed. Lippincott Williams & Wilkins; 2014.
3. Klatt EC. Robbins and Cotran Atlas of Pathology. 4th ed. Elsevier; 2020.
